Personalis Inc (PSNL)
3.38
-0.08
(-2.31%)
USD |
NASDAQ |
Nov 21, 16:00
3.385
0.00 (0.00%)
Pre-Market: 20:00
Personalis Debt to Equity Ratio: 0.0099 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0099 |
| June 30, 2024 | 0.0203 |
| March 31, 2024 | 0.0137 |
| December 31, 2023 | 0.0127 |
| September 30, 2023 | 0.0027 |
| June 30, 2023 | 0.0047 |
| March 31, 2023 | 0.0136 |
| December 31, 2022 | 0.0102 |
| September 30, 2022 | 0.0105 |
| June 30, 2022 | 0.0066 |
| March 31, 2022 | 0.0124 |
| December 31, 2021 | 0.0058 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0106 |
| June 30, 2021 | 0.013 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.1627 |
| March 31, 2019 | -0.9333 |
| December 31, 2018 | -0.047 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0203
Maximum
Jun 2024
0.0073
Average
0.0083
Median
Debt to Equity Ratio Benchmarks
| Repligen Corp | 0.2586 |
| Axogen Inc | 0.4755 |
| CareDx Inc | 0.00 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 239.89M |
| Total Liabilities (Quarterly) | 73.13M |
| Shareholders Equity (Quarterly) | 166.76M |
| Current Ratio | 4.676 |
| Net Debt Paydown Yield | -0.04% |